(505) 254-7784 pchelp@pcsanm.org
  • About Us
    • Mission Statement
    • Our Board
    • Organization Description
  • Contact Us
  • Donate Today!
0 Items
Prostate Cancer Support Association of New Mexico
  • Home
  • Start Here
    • Beginner’s Guide
    • Next Steps
  • Meetings
  • Resources
  • Education & Info
    • Helpful Prostate Cancer-Related Websites
    • NM Cancer Resources & Support
    • News You Can Use
    • Articles of Interest
    • For Medical Professionals
  • Annual Conference
  • Newsletters
  • Early Detection
    • Early Detection
    • Free PSA Test
Select Page

Importance of Lifestyle and Prevention of Complications in Advanced Prostate Cancer

by admin_63069 | May 15, 2022 | News You Can Use

How to Take Care of the Heart?

How Radiologists Could Use Cryoablation to Put Cancer Pain on Ice

by admin_63069 | May 11, 2022 | News You Can Use

J. David Prologo, MD, FSIR, ABOM-D, an interventional radiologist at Emory Healthcare, details how cryoablation can be used by radiologists to manage pain in patients with cancer.

Survival Benefit of Enzalutamide Plus ADT in mHSPC

by admin_63069 | May 7, 2022 | News You Can Use

Results from the phase 3 ARCHES trial confirm the survival benefit of enzalutamide plus androgen deprivation therapy in patients with metastatic hormone-sensitive prostate cancer.

Radiation Therapy for Prostate Cancer Continues to Evolve

by admin_63069 | May 3, 2022 | News You Can Use

The last century of development in radiation oncology has been about targeting.

Is Genetically-Adjusted PSA More Accurate Than PSA Alone for Prostate Cancer Screening?

by admin_63069 | Apr 28, 2022 | News You Can Use

According to new research, genetic determinants of PSA proved to robustly predict prostate cancer diagnoses and improve the detection of aggressive disease; however, larger and more diverse studies are still required.

Is It Time to Remove ‘Cancer’ Label From Low-Risk Prostate Tumors?

by admin_63069 | Apr 25, 2022 | News You Can Use

A team of experts is recommending that doctors forgo describing early, low-grade prostate tumors as “cancers” as a way to ease anxiety among patients and their families and reduce unnecessary treatment.
« Older Entries

What’s New

  • Brachytherapy vs EBRT vs SBRT for Low/Intermediate Risk Disease
  • FDA Expedites Review of Nubeqa Combination for Metastatic, Hormone-Sensitive Prostate Cancer
  • Importance of Lifestyle and Prevention of Complications in Advanced Prostate Cancer
  • “Shooting for the Moon” Means Reducing Metastatic Prostate Cancer Diagnoses
  • Genetically Adjusted PSA Screening

Disclaimers:

PCSANM provides education, information, and support, not medical advice. Please contact your physician for all your medical concerns. No copyrighted material belonging to others is knowingly used without permission. If any is inadvertently used without permission, please contact our office. Articles are selected from a variety of sources to give as wide a range of content as possible. PCSANM does not endorse or approve, and assumes no responsibility for, the content, accuracy, or completeness of the information presented.

2533 Virginia St. NE, Suite C Albuquerque, NM 87110

Phone: (505) 254-7784
Toll Free: (800) 278-7678
Fax: (505) 254-7786

Email: pchelp@pcsanm.org